Glenmark starts phase-3 clinical trials on Favipiravir for COVID-19 patients in India

The Mumbai-based company had received approval from Drug Controller General of India (DCGI) last month to conduct clinical trials of Favipiravir antiviral tablets for the treatment of COVID-19 patients.